The treatment of poor risk nonseminomatous testicular tumors.
A total of 14 patients with nonseminomatous testicular tumors presenting with characteristics indicative of a poor prognosis were treated with cytoreductive chemotherapy, surgery and immediate reinduction chemotherapy. Of the 14 patients 12 presently are alive without evidence of disease (median followup 18 months). This new approach has improved significantly the outcome of these patients.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002369:Castration; D003131:Combined Modality Therapy; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D011379:Prognosis; D012306:Risk; D013724:Teratoma / Q000401:mortality / Q000628:therapy*; D013736:Testicular Neoplasms / Q000401:mortality / Q000628:therapy*